Sinopsis
A selection of the best interviews conducted by physician leaders and recorded at cardiology conferences around the globe.
Episodios
-
Episode 47: INTREPID
07/06/2018 Duración: 03minEarly results with a new device being developed for transcatheter MV replacement are promising, Paul Sorajja tells C. Michael Gibson.
-
Episode 46: DAPT-STEMI
18/05/2018 Duración: 05minC. Michael Gibson gets the details from DAPT-STEMI from Elvin Kedhi.
-
Episode 34: TRACER
08/01/2018 Duración: 04minTRACER: 6-Month Outcomes of Transcatheter MV Neochordal Repair in Patients With Severe Primary Mitral Regurgitation
-
Episode 35: TENDYNE Trial
08/01/2018 Duración: 03minDr. C. Michael Gibson talks to Dr. David W. M. Muller about TENDYNE: 1-Year Outcomes of Transcatheter MV Replacement in Patients With Severe Mitral Regurgitation
-
Episode 33: DKCRUSH-V Trial
06/12/2017 Duración: 03minDr. C. Michael Gisbon talks to Dr. Shao-Liang Chen about the DKCRUSH-V: A Randomized Trial of Double Kissing Crush vs Provisional Stenting for Treatment of Distal Left Main Bifurcation Lesions.
-
Episode 31: PLATINUM DIVERSITY - Outcomes With Coronary Stenting in Women and Minorities
06/12/2017 Duración: 08minC. Michael Gibson reviews new registry results with Wayne Batchelor.
-
Episode 32: COLOR
30/11/2017 Duración: 08minListen to C. Michael Gibson in conversation with Giora Weisz. Color: A Multicenter Registry Looking at Lipid-Rich Plaque & 2-Year Outcomes After Stenting
-
Episode 30: PARTNER 2 Quality of Life
20/09/2017 Duración: 03minC. Michael Gibson discusses health-status benefits in intermediate-risk patients treated with surgical or transcatheter aortic valve replacement.
-
Episode 29: ILLUMENATE US
06/09/2017 Duración: 02minC. Michael Gibson sits down with Sean Lyden to discuss the results.
-
Episode 28: The AMULET OBSERVATIONAL STUDY
06/09/2017 Duración: 05minC. Michael Gibson speaks with David Hildick-Smith about left atrial closure devices for stroke prevention.
-
Episode 27: The WATCHMAN US Postapproval Study
15/08/2017 Duración: 05minC. Michael Gibson reviews the results with Vivek Reddy.
-
Episode 26: PARTNER 1 5-YEAR ECHO - Long-term Hemodynamic and Structural Outcomes
02/08/2017 Duración: 05minC. Michael Gibson discusses the trial findings with Pamela Douglas.